Compare Lustrum:TAISHO PHARMACEUTICAL CO.,LTD.:4535

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index TAISHO PHARMACEUTICAL CO.,LTD. Go to web site 4535 Medicals 1st TSE March 1, 2000 1963.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

TAISHO PHARMACEUTICAL CO.,LTD. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

TAISHO PHARMACEUTICAL CO.,LTD. Balance Sheet 2011年3月期 TAISHO PHARMACEUTICAL CO.,LTD. Balance Sheet 2010年3月期 TAISHO PHARMACEUTICAL CO.,LTD. Balance Sheet 2009年3月期 TAISHO PHARMACEUTICAL CO.,LTD. Balance Sheet 2008年3月期 TAISHO PHARMACEUTICAL CO.,LTD. Balance Sheet 2007年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2011 March 31, 2010 March 31, 2009 March 31, 2008 March 31, 2007
Cash and Cash Equivalents
(Percent)
133,422up
(21.6%)up
113,223down
(18.7%)down
115,907down
(19.6%)down
153,150up
(24.4%)up
133,340
(21.1%)
Other Current AssetsHelp
(Percent)
99,748down
(16.1%)down
102,463up
(16.9%)down
99,965up
(16.9%)up
96,311down
(15.4%)down
107,074
(16.9%)
Tangible Fixed AssetsHelp
(Percent)
90,249down
(14.6%)down
90,746down
(15.0%)down
92,961down
(15.7%)up
97,148down
(15.5%)up
97,795
(15.5%)
Intangible Fixed AssetHelp
(Percent)
16,989down
(2.7%)down
20,058up
(3.3%)up
7,624up
(1.3%)up
6,844down
(1.1%)down
7,376
(1.2%)
Investments and OthersHelp
(Percent)
264,629down
(42.8%)down
265,715down
(43.8%)down
272,627up
(46.1%)up
257,859down
(41.1%)down
286,204
(45.3%)
Total AssetsHelp
(Percent)
618,434
(100%)
606,443
(100%)
591,568
(100%)
627,218
(100%)
631,920
(100%)
Total Current LiabilitiesHelp
(Percent)
59,859up
(9.7%)up
55,680up
(9.2%)up
54,130down
(9.2%)up
55,639up
(8.9%)up
53,905
(8.5%)
Total Long-term LiabilitiesHelp
(Percent)
34,072up
(5.5%)up
33,212up
(5.5%)up
32,271up
(5.5%)up
31,503down
(5.0%)down
32,395
(5.1%)
Shareholder's EquityHelp
(Percent)
524,503up
(84.8%)down
517,551up
(85.3%)down
505,167down
(85.4%)down
540,076down
(86.1%)down
545,620
(86.3%)
Total LiabilitiesHelp
(Percent)
618,434
(100%)
606,443
(100%)
591,568
(100%)
627,218
(100%)
631,920
(100%)

TAISHO PHARMACEUTICAL CO.,LTD. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

TAISHO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2011年3月期 TAISHO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2010年3月期 TAISHO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2009年3月期 TAISHO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2008年3月期 TAISHO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2007年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2011 March 31, 2010 March 31, 2009 March 31, 2008 March 31, 2007
Amount of Sales
(Percent)
268,632
(100%)
258,441
(100%)
256,213
(100%)
249,655
(100%)
242,071
(100%)
Total Sales
(Percent)
268,632
(100%)
258,441
(100%)
256,213
(100%)
249,655
(100%)
242,071
(100%)
Cost of SalesHelp
(Percent)
96,460up
(35.9%)up
91,815up
(35.5%)up
86,889up
(33.9%)down
85,295up
(34.2%)up
82,224
(34.0%)
Other Costs and RevenueHelp 137,280down
(51.1%)down
147,141down
(56.9%)down
160,509up
(62.6%)up
139,349down
(55.8%)down
144,419
(59.7%)
Total CostsHelp 233,740 238,956 247,398 224,644 226,643
Net RevenueHelp 172,172up
(64.1%)down
166,626down
(64.5%)down
169,324up
(66.1%)up
164,360up
(65.8%)down
159,847
(66.0%)
Earnings Before TaxHelp 53,006up
(19.7%)up
35,790up
(13.8%)up
26,759down
(10.4%)down
40,997up
(16.4%)up
29,003
(12.0%)
Net IncomeHelp 34,892up
(13.0%)up
19,485up
(7.5%)up
8,815down
(3.4%)down
25,011up
(10.0%)up
15,428
(6.4%)
当期純利益 34,892 19,485 8,815 25,011 15,428

TAISHO PHARMACEUTICAL CO.,LTD. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

TAISHO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2011年3月期 TAISHO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2010年3月期 TAISHO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2009年3月期 TAISHO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2008年3月期 TAISHO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2007年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2011 March 31, 2010 March 31, 2009 March 31, 2008 March 31, 2007
Operating Cash Flow(OFC)Help
(Percent)
46,493up
(100.0%)up
39,475up
(77.5%)down
35,782down
(82.2%)down
50,746up
(100.0%)up
29,639
(55.0%)
Investing Cash Flow(ICF)Help
(Percent)
-792down
(-1.7%)down
11,244up
(22.1%)up
-12,530up
(-28.8%)up
-35,064down
(-69.1%)down
-22,814
(-42.3%)
Financing Cash FlowHelp
(Percent)
-18,377up
(-39.5%)down
-18,837up
(-37.0%)up
-29,429down
(-67.6%)down
-11,431up
(-22.5%)up
-31,083
(-57.7%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
-677down
(-1.5%)down
212up
(0.4%)up
-1,581down
(-3.6%)down
-10down
(0.0%)down
444
(0.8%)
Net Increase and Decrease in Cash and Cash Equivalentsn 26,645down
(57.3%)down
32,094up
(63.0%)up
-7,759down
(-17.8%)down
4,240up
(8.4%)up
-23,814
(-44.2%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

TAISHO PHARMACEUTICAL CO.,LTD.

Company where related level is highHelp

WAKAMOTO PHARMACEUTICAL CO.,LTD.
Oncolys BioPharma Inc.
RIBOMIC Inc.
SEIKAGAKU CORPORATION
Eisai Co.,Ltd.
Perseus Proteomics Inc.
KAINOS Laboratories,Inc.
Cyfuse Biomedical K.K.
SanBio Company Limited
SAWAI GROUP HOLDINGS Co., Ltd.